한글목차

Technavio사는 골관절염 치료제 시장이 2023-2028년간 45억 7,360만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 9.49%로 성장할 것으로 예측했습니다.

골관절염 치료제 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 골관절염 이환율 증가, 질환 관리를 위한 가이드라인 이용 가능성, 개선된 진단 방법 이용 가능성에 의해 시장 성장이 촉진되고 있습니다.

본 조사에서는 연구개발 확대가 향후 몇 년간 골관절염 치료제 시장 성장을 가속하는 주요인 중 하나로 보고 있습니다. 또한 전략적 제휴 증가, 유전자 치료와 바이오 세라피 진보가 시장의 큰 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제3장 시장 규모 평가

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 골관절염 치료제 시장(2018-2022년)
• 제품별 부문 분석(2018-2022년)
• 유형별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 제품별

• 시장 세분화
• 비교 : 제품별
• 진통제와 NSAID : 시장 규모와 예측(2023-2028년)
• 코르티코스테로이드 : 시장 규모와 예측(2023-2028년)
• 관절 보호약 : 시장 규모와 예측(2023-2028년)
• 기타 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 제품별

제7장 시장 세분화 : 유형별

• 시장 세분화
• 비교 : 유형별
• 발목 골관절염 : 시장 규모와 예측(2023-2028년)
• 퇴행성 고관절증 : 시장 규모와 예측(2023-2028년)
• 퇴행성 슬관절증 : 시장 규모와 예측(2023-2028년)
• 기타 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 유형별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 일본 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역별

제10장 성장 촉진요인, 과제, 기회 및 억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회 및 성장 억제요인

제11장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계 리스크

제12장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• Abbott Laboratories
• Anika Therapeutics Inc.
• Bayer AG
• Bioventus LLC
• Boehringer Ingelheim International GmbH
• F. Hoffmann La Roche Ltd.
• Ferring BV
• Fidia Farmaceutici Spa
• GlaxoSmithKline Plc
• Horizon Therapeutics Plc
• Johnson and Johnson Services Inc.
• Novartis AG
• Sanofi SA
• Viatris Inc.
• Zimmer Biomet Holdings Inc.

제13장 부록

영문목차

Technavio has been monitoring the osteoarthritis therapeutics market and is forecast to grow by USD 4573.6 mn during 2023-2028, accelerating at a CAGR of 9.49% during the forecast period. Our report on the osteoarthritis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of osteoarthritis, availability of guidelines for disease management, and availability of improved diagnostic modalities.

Technavio's osteoarthritis therapeutics market is segmented as below:

By Product

• Analgesics and NSAIDs
• Corticosteriods
• Viscosupplements
• Others

By Type

• Ankle osteoarthritis
• Hip osteoarthritis
• Knee osteoarthritis
• Others

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the expanding research and development as one of the prime reasons driving the osteoarthritis therapeutics market growth during the next few years. Also, rising number of strategic collaborations and advancements in gene therapy and biotherapy will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the osteoarthritis therapeutics market covers the following areas:

• Osteoarthritis therapeutics market sizing
• Osteoarthritis therapeutics market forecast
• Osteoarthritis therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading osteoarthritis therapeutics market vendors that include Abbott Laboratories, Alvogen Iceland ehf, Anika Therapeutics Inc., Avanos Medical Inc., Bayer AG, Bioventus LLC, Boehringer Ingelheim International GmbH, F. Hoffmann La Roche Ltd., Ferring BV, Fidia Farmaceutici Spa, GlaxoSmithKline Plc, Hanmi Pharm Co. Ltd., Horizon Therapeutics Plc, Johnson and Johnson Services Inc., Novartis AG, Pacira BioSciences Inc., Pharmed Ltd., Sanofi SA, Viatris Inc., and Zimmer Biomet Holdings Inc.. Also, the osteoarthritis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Osteoarthritis Therapeutics Market 2018 - 2022
  • Historic Market Size - Data Table on Global Osteoarthritis Therapeutics Market 2018 - 2022 ($ million)
• 4.2 Product segment analysis 2018 - 2022
  • Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.3 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
  • Chart on Product - Market share 2023-2028 (%)
  • Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
• 6.3 Analgesics and NSAIDs - Market size and forecast 2023-2028
  • Chart on Analgesics and NSAIDs - Market size and forecast 2023-2028 ($ million)
  • Data Table on Analgesics and NSAIDs - Market size and forecast 2023-2028 ($ million)
  • Chart on Analgesics and NSAIDs - Year-over-year growth 2023-2028 (%)
  • Data Table on Analgesics and NSAIDs - Year-over-year growth 2023-2028 (%)
• 6.4 Corticosteriods - Market size and forecast 2023-2028
  • Chart on Corticosteriods - Market size and forecast 2023-2028 ($ million)
  • Data Table on Corticosteriods - Market size and forecast 2023-2028 ($ million)
  • Chart on Corticosteriods - Year-over-year growth 2023-2028 (%)
  • Data Table on Corticosteriods - Year-over-year growth 2023-2028 (%)
• 6.5 Viscosupplements - Market size and forecast 2023-2028
  • Chart on Viscosupplements - Market size and forecast 2023-2028 ($ million)
  • Data Table on Viscosupplements - Market size and forecast 2023-2028 ($ million)
  • Chart on Viscosupplements - Year-over-year growth 2023-2028 (%)
  • Data Table on Viscosupplements - Year-over-year growth 2023-2028 (%)
• 6.6 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.7 Market opportunity by Product
  • Market opportunity by Product ($ million)
  • Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 7.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 7.3 Ankle osteoarthritis - Market size and forecast 2023-2028
  • Chart on Ankle osteoarthritis - Market size and forecast 2023-2028 ($ million)
  • Data Table on Ankle osteoarthritis - Market size and forecast 2023-2028 ($ million)
  • Chart on Ankle osteoarthritis - Year-over-year growth 2023-2028 (%)
  • Data Table on Ankle osteoarthritis - Year-over-year growth 2023-2028 (%)
• 7.4 Hip osteoarthritis - Market size and forecast 2023-2028
  • Chart on Hip osteoarthritis - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hip osteoarthritis - Market size and forecast 2023-2028 ($ million)
  • Chart on Hip osteoarthritis - Year-over-year growth 2023-2028 (%)
  • Data Table on Hip osteoarthritis - Year-over-year growth 2023-2028 (%)
• 7.5 Knee osteoarthritis - Market size and forecast 2023-2028
  • Chart on Knee osteoarthritis - Market size and forecast 2023-2028 ($ million)
  • Data Table on Knee osteoarthritis - Market size and forecast 2023-2028 ($ million)
  • Chart on Knee osteoarthritis - Year-over-year growth 2023-2028 (%)
  • Data Table on Knee osteoarthritis - Year-over-year growth 2023-2028 (%)
• 7.6 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.7 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape2023-2028 (%)
  • Data Table on Market share By Geographical Landscape2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.9 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.10 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity by geography
  • Market opportunity By Geographical Landscape($ million)
  • Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
• 12.4 Anika Therapeutics Inc.
  • Anika Therapeutics Inc. - Overview
  • Anika Therapeutics Inc. - Product / Service
  • Anika Therapeutics Inc. - Key offerings
• 12.5 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
• 12.6 Bioventus LLC
  • Bioventus LLC - Overview
  • Bioventus LLC - Business segments
  • Bioventus LLC - Key offerings
  • Bioventus LLC - Segment focus
• 12.7 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key offerings
• 12.8 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 12.9 Ferring BV
  • Ferring BV - Overview
  • Ferring BV - Product / Service
  • Ferring BV - Key offerings
• 12.10 Fidia Farmaceutici Spa
  • Fidia Farmaceutici Spa - Overview
  • Fidia Farmaceutici Spa - Product / Service
  • Fidia Farmaceutici Spa - Key offerings
• 12.11 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
• 12.12 Horizon Therapeutics Plc
  • Horizon Therapeutics Plc - Overview
  • Horizon Therapeutics Plc - Product / Service
  • Horizon Therapeutics Plc - Key offerings
• 12.13 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
• 12.14 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
• 12.15 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
• 12.16 Viatris Inc.
  • Viatris Inc. - Overview
  • Viatris Inc. - Business segments
  • Viatris Inc. - Key news
  • Viatris Inc. - Key offerings
  • Viatris Inc. - Segment focus
• 12.17 Zimmer Biomet Holdings Inc.
  • Zimmer Biomet Holdings Inc. - Overview
  • Zimmer Biomet Holdings Inc. - Business segments
  • Zimmer Biomet Holdings Inc. - Key news
  • Zimmer Biomet Holdings Inc. - Key offerings
  • Zimmer Biomet Holdings Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 market analysis
  • market analysis
• 13.10 List of abbreviations
  • List of abbreviations